Transition report pursuant to Rule 13a-10 or 15d-10

Document and Entity Information

Document and Entity Information (USD $)
In Millions, except Share data, unless otherwise specified
6 Months Ended
Jun. 30, 2014
Aug. 27, 2014
Dec. 31, 2013
Document and Entity Information [Abstract]      
Entity Registrant Name DelMar Pharmaceuticals, Inc.    
Entity Central Index Key 0001498382    
Trading Symbol dmpi    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Current Fiscal Year End Date --06-30    
Entity Filer Category Smaller Reporting Company    
Entity Common Stock, Shares Outstanding   30,109,987  
Document Type 10-K    
Document Period End Date Jun. 30, 2014    
Amendment Flag false    
Document Fiscal Year Focus 2014    
Document Fiscal Period Focus FY    
Entity Well-known Seasoned Issuer No    
Entity Public Float     $ 18.6